Tapewire

NYSE · USD

WST

WEST PHARMACEUTICAL SERVICES INC

Export transactions ↓
Tapewire entity
3201
SEC CIK
0000105770
Parsed reports
469

Last 12 months

Inside the activity.

0 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202602
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202606
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 08, 2025 Filed Dec 10, 2025 15:33 UTC
Finch Norman D. Jr.SVP, GC & Corporate Secretary
GrantRst. Stock Unit · Derivative 192 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000105770-25-000100 · form4.xml · derivative · entry 1

Finch Norman D. Jr. · CIK 0001577064 · SVP, GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192

Underlying: Common Stock · 192 shares

Expires not disclosed

F1 · derivative.exercise_date: This award vests in four equal installments beginning on December 8, 2026.

F1 · derivative.expiration_date: This award vests in four equal installments beginning on December 8, 2026.

Read SEC document
September 30, 2025 Filed Oct 2, 2025 16:56 UTC GrantPhantom Stock Unit · Derivative 48 $262.33 $12,591.84
Disclosure

SEC source: 0000105770-25-000085 · form4.xml · derivative · entry 2

HAUGEN JANET BRUTSCHEA · CIK 0001185136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162.161

Underlying: Common Stock · 48 shares

Expires not disclosed

F2 · derivative.exercise_price: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.

F2 · derivative.exercise_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.

F2 · derivative.expiration_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.

Read SEC document
August 11, 2025 Filed Aug 12, 2025 23:19 UTC
McMahon Robert W.SVP & Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 7,137 $240.33 Strike: $240.33 $1,715,235.21
Disclosure

SEC source: 0000105770-25-000074 · form4.xml · derivative · entry 4

McMahon Robert W. · CIK 0001608730 · SVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,137

Underlying: Common Stock · 7,137 shares

Expires 2035-08-11

F2 · derivative.exercise_date: This award vests in four equal installments beginning on August 11, 2026.

Read SEC document
August 11, 2025 Filed Aug 12, 2025 23:19 UTC
McMahon Robert W.SVP & Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 7,647 $240.33 Strike: $240.33 $1,837,803.51
Disclosure

SEC source: 0000105770-25-000074 · form4.xml · derivative · entry 3

McMahon Robert W. · CIK 0001608730 · SVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,647

Underlying: Common Stock · 7,647 shares

Expires 2035-08-11

F2 · derivative.exercise_date: This award vests in four equal installments beginning on August 11, 2026.

Read SEC document
August 11, 2025 Filed Aug 12, 2025 23:19 UTC
McMahon Robert W.SVP & Chief Financial Officer
GrantRst. Stock Unit · Derivative 3,168 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000105770-25-000074 · form4.xml · derivative · entry 2

McMahon Robert W. · CIK 0001608730 · SVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,168

Underlying: Common Stock · 3,168 shares

Expires not disclosed

F2 · derivative.exercise_date: This award vests in four equal installments beginning on August 11, 2026.

F2 · derivative.expiration_date: This award vests in four equal installments beginning on August 11, 2026.

Read SEC document
August 11, 2025 Filed Aug 12, 2025 23:19 UTC
McMahon Robert W.SVP & Chief Financial Officer
GrantRst. Stock Unit · Derivative 12,670 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000105770-25-000074 · form4.xml · derivative · entry 1

McMahon Robert W. · CIK 0001608730 · SVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,670

Underlying: Common Stock · 12,670 shares

Expires not disclosed

F1 · derivative.exercise_date: This award vests in three installments. 4,223 shares will vest six months from the grant date, 6,335 shares will vest 12 months from the grant date, and 2,112 shares will vest 24 months from the grant date.

F1 · derivative.expiration_date: This award vests in three installments. 4,223 shares will vest six months from the grant date, 6,335 shares will vest 12 months from the grant date, and 2,112 shares will vest 24 months from the grant date.

Read SEC document
June 30, 2025 Filed Jul 1, 2025 23:44 UTC GrantPhantom Stock Unit · Derivative 58 $218.80 $12,690.40
Disclosure

SEC source: 0000105770-25-000055 · form4.xml · derivative · entry 2

HAUGEN JANET BRUTSCHEA · CIK 0001185136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114.06

Underlying: Common Stock · 58 shares

Expires not disclosed

F1 · derivative.exercise_price: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.

F1 · derivative.exercise_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.

F1 · derivative.expiration_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.

Read SEC document
May 12, 2025 Filed May 14, 2025 20:04 UTC
Campbell Shane AldenSVP, Proprietary Segment
GrantStock Options (Right to Buy) · Derivative 2,852 $219.46 Strike: $219.46 $625,899.92
Disclosure

SEC source: 0001127602-25-014250 · form4.xml · derivative · entry 3

Campbell Shane Alden · CIK 0002068522 · SVP, Proprietary Segment

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,852

Underlying: Stock Options (Right to Buy) · 2,852 shares

Expires 2035-05-12

F1 · derivative.exercise_date: This award vests in four equal annual installments beginning on May 12, 2026.

Read SEC document
May 12, 2025 Filed May 14, 2025 20:04 UTC
Campbell Shane AldenSVP, Proprietary Segment
GrantRst. Stock Unit · Derivative 1,182 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-014250 · form4.xml · derivative · entry 2

Campbell Shane Alden · CIK 0002068522 · SVP, Proprietary Segment

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,182

Underlying: Common Stock · 1,182 shares

Expires not disclosed

F1 · derivative.exercise_date: This award vests in four equal annual installments beginning on May 12, 2026.

F1 · derivative.expiration_date: This award vests in four equal annual installments beginning on May 12, 2026.

Read SEC document
May 12, 2025 Filed May 14, 2025 20:04 UTC
Campbell Shane AldenSVP, Proprietary Segment
GrantRst. Stock Unit · Derivative 1,891 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-014250 · form4.xml · derivative · entry 1

Campbell Shane Alden · CIK 0002068522 · SVP, Proprietary Segment

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,891

Underlying: Common Stock · 1,891 shares

Expires not disclosed

F1 · derivative.exercise_date: This award vests in four equal annual installments beginning on May 12, 2026.

F1 · derivative.expiration_date: This award vests in four equal annual installments beginning on May 12, 2026.

Read SEC document
May 06, 2025 Filed May 8, 2025 21:04 UTC GrantCommon Stock 1,071 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-013728 · form4.xml · nonDerivative · entry 1

Michels Douglas A · CIK 0001295391 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,171.05

F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

Read SEC document
May 06, 2025 Filed May 8, 2025 21:00 UTC
Pucci PaoloDirector
GrantCommon Stock 1,071 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-013724 · form4.xml · nonDerivative · entry 1

Pucci Paolo · CIK 0001436861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,946.95

F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

Read SEC document
May 06, 2025 Filed May 8, 2025 20:54 UTC GrantCommon Stock 1,071 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-013718 · form4.xml · nonDerivative · entry 1

HAUGEN JANET BRUTSCHEA · CIK 0001185136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,318.16

F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

Read SEC document
May 06, 2025 Filed May 8, 2025 20:50 UTC GrantCommon Stock 1,071 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-013716 · form4.xml · nonDerivative · entry 1

FRIEL ROBERT F · CIK 0001224110 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,681.98

F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

Read SEC document
May 06, 2025 Filed May 8, 2025 20:42 UTC GrantCommon Stock 1,071 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-013709 · form4.xml · nonDerivative · entry 1

LAI GOLDMAN MYLA · CIK 0001168581 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,423.93

F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

Read SEC document
May 06, 2025 Filed May 8, 2025 20:38 UTC
Joseph MollyDirector
GrantCommon Stock 1,071 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-013705 · form4.xml · nonDerivative · entry 1

Joseph Molly · CIK 0001709261 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,884.44

F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.

Read SEC document
May 06, 2025 Filed May 8, 2025 20:35 UTC GrantCommon Stock 1,071 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-013704 · form4.xml · nonDerivative · entry 1

Hofmann Thomas W · CIK 0001174597 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,637.12

F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.

Read SEC document
May 06, 2025 Filed May 8, 2025 20:32 UTC GrantCommon Stock 1,071 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-013700 · form4.xml · nonDerivative · entry 1

Keller Deborah L · CIK 0001352992 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,656.72

F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

Read SEC document
May 06, 2025 Filed May 8, 2025 20:30 UTC GrantCommon Stock 1,071 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-013696 · form4.xml · nonDerivative · entry 1

Feehery William F · CIK 0001543193 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,363.13

F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

Read SEC document
May 06, 2025 Filed May 8, 2025 20:28 UTC GrantCommon Stock 1,071 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-013693 · form4.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,708.407

F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.

Read SEC document
May 06, 2025 Filed May 8, 2025 20:26 UTC GrantCommon Stock 1,071 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-013688 · form4.xml · nonDerivative · entry 1

BUTHMAN MARK A · CIK 0001223783 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,860.9294

F1 · shares: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.

Read SEC document
March 31, 2025 Filed Apr 2, 2025 17:09 UTC GrantPhantom Stock Unit · Derivative 56 $223.88 $12,537.28
Disclosure

SEC source: 0001127602-25-011013 · form4.xml · derivative · entry 2

HAUGEN JANET BRUTSCHEA · CIK 0001185136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56

Underlying: Common Stock · 56 shares

Expires not disclosed

F1 · derivative.exercise_price: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.

F1 · derivative.exercise_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.

F1 · derivative.expiration_date: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:44 UTC
Birkett BernardSr VP, Chief Financial Officer
GrantRst. Stock Unit · Derivative 1,740 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-006135 · form4.xml · derivative · entry 6

Birkett Bernard · CIK 0001658001 · Sr VP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,740

Underlying: Common Stock · 1,740 shares

Expires not disclosed

F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026.

F1 · derivative.expiration_date: This award vests in four equal installments beginning on February 18, 2026.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:44 UTC
Birkett BernardSr VP, Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 4,020 $0.00 Strike: $211.00 $0.00
Disclosure

SEC source: 0001127602-25-006135 · form4.xml · derivative · entry 5

Birkett Bernard · CIK 0001658001 · Sr VP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,020

Underlying: Common Stock · 4,020 shares

Expires 2035-02-18

F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:44 UTC
Birkett BernardSr VP, Chief Financial Officer
Tax withholdingCommon Stock 35.606 $211.00 $7,512.87
Disclosure

SEC source: 0001127602-25-006135 · form4.xml · nonDerivative · entry 4

Birkett Bernard · CIK 0001658001 · Sr VP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,520.38

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:44 UTC
Birkett BernardSr VP, Chief Financial Officer
Exercise / conversionCommon Stock 124.977 $211.00 $26,370.15
Disclosure

SEC source: 0001127602-25-006135 · form4.xml · nonDerivative · entry 3

Birkett Bernard · CIK 0001658001 · Sr VP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,555.986

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:44 UTC
Birkett BernardSr VP, Chief Financial Officer
Tax withholdingCommon Stock 237.764 $211.00 $50,168.20
Disclosure

SEC source: 0001127602-25-006135 · form4.xml · nonDerivative · entry 2

Birkett Bernard · CIK 0001658001 · Sr VP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,431.009

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:44 UTC
Birkett BernardSr VP, Chief Financial Officer
Exercise / conversionCommon Stock 779.353 $211.00 $164,443.48
Disclosure

SEC source: 0001127602-25-006135 · form4.xml · nonDerivative · entry 1

Birkett Bernard · CIK 0001658001 · Sr VP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,668.773

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:16 UTC
Reiss-Clark CindyChief Commercial Officer
GrantRst. Stock Unit · Derivative 503 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-006123 · form4.xml · derivative · entry 4

Reiss-Clark Cindy · CIK 0001916513 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 503

Underlying: Common Stock · 503 shares

Expires not disclosed

F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026.

F1 · derivative.expiration_date: This award vests in four equal installments beginning on February 18, 2026.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:16 UTC
Reiss-Clark CindyChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 1,162 $0.00 Strike: $211.00 $0.00
Disclosure

SEC source: 0001127602-25-006123 · form4.xml · derivative · entry 3

Reiss-Clark Cindy · CIK 0001916513 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,162

Underlying: Common Stock · 1,162 shares

Expires 2035-02-18

F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:16 UTC
Reiss-Clark CindyChief Commercial Officer
Tax withholdingCommon Stock 83.179 $211.00 $17,550.77
Disclosure

SEC source: 0001127602-25-006123 · form4.xml · nonDerivative · entry 2

Reiss-Clark Cindy · CIK 0001916513 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,047.329

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:16 UTC
Reiss-Clark CindyChief Commercial Officer
Exercise / conversionCommon Stock 246.162 $211.00 $51,940.18
Disclosure

SEC source: 0001127602-25-006123 · form4.xml · nonDerivative · entry 1

Reiss-Clark Cindy · CIK 0001916513 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,130.508

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:13 UTC
MacKay Kimberly BanksSVP, GC & Corporate Secretary
GrantRst. Stock Unit · Derivative 503 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-006120 · form4.xml · derivative · entry 4

MacKay Kimberly Banks · CIK 0001835699 · SVP, GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 503

Underlying: Common Stock · 503 shares

Expires not disclosed

F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026.

F1 · derivative.expiration_date: This award vests in four equal installments beginning on February 18, 2026.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:13 UTC
MacKay Kimberly BanksSVP, GC & Corporate Secretary
GrantStock Option (Right to Buy) · Derivative 1,162 $0.00 Strike: $211.00 $0.00
Disclosure

SEC source: 0001127602-25-006120 · form4.xml · derivative · entry 3

MacKay Kimberly Banks · CIK 0001835699 · SVP, GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,162

Underlying: Common Stock · 1,162 shares

Expires 2035-02-18

F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:13 UTC
MacKay Kimberly BanksSVP, GC & Corporate Secretary
Tax withholdingCommon Stock 92.693 $211.00 $19,558.22
Disclosure

SEC source: 0001127602-25-006120 · form4.xml · nonDerivative · entry 2

MacKay Kimberly Banks · CIK 0001835699 · SVP, GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,511.933

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:13 UTC
MacKay Kimberly BanksSVP, GC & Corporate Secretary
Exercise / conversionCommon Stock 246.162 $211.00 $51,940.18
Disclosure

SEC source: 0001127602-25-006120 · form4.xml · nonDerivative · entry 1

MacKay Kimberly Banks · CIK 0001835699 · SVP, GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,604.626

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:11 UTC
Favorite Annette FSr. VP & Chief HR Officer
GrantRst. Stock Unit · Derivative 542 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-006119 · form4.xml · derivative · entry 4

Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 542

Underlying: Common Stock · 542 shares

Expires not disclosed

F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026.

F1 · derivative.expiration_date: This award vests in four equal installments beginning on February 18, 2026.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:11 UTC
Favorite Annette FSr. VP & Chief HR Officer
GrantStock Option (Right to Buy) · Derivative 1,251 $0.00 Strike: $211.00 $0.00
Disclosure

SEC source: 0001127602-25-006119 · form4.xml · derivative · entry 3

Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,251

Underlying: Common Stock · 1,251 shares

Expires 2035-02-18

F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:11 UTC
Favorite Annette FSr. VP & Chief HR Officer
Tax withholdingCommon Stock 83.794 $211.00 $17,680.53
Disclosure

SEC source: 0001127602-25-006119 · form4.xml · nonDerivative · entry 2

Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,738.7407

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:11 UTC
Favorite Annette FSr. VP & Chief HR Officer
Exercise / conversionCommon Stock 246.162 $211.00 $51,940.18
Disclosure

SEC source: 0001127602-25-006119 · form4.xml · nonDerivative · entry 1

Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,822.5347

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:09 UTC
Winters ChadVP, Chief Accounting Officer
GrantRst. Stock Unit · Derivative 356 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-006118 · form4.xml · derivative · entry 4

Winters Chad · CIK 0001811424 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 356

Underlying: Common Stock · 356 shares

Expires not disclosed

F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026.

F1 · derivative.expiration_date: This award vests in four equal installments beginning on February 18, 2026.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:09 UTC
Winters ChadVP, Chief Accounting Officer
GrantStock Option (Right to Buy) · Derivative 822 $0.00 Strike: $211.00 $0.00
Disclosure

SEC source: 0001127602-25-006118 · form4.xml · derivative · entry 3

Winters Chad · CIK 0001811424 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 822

Underlying: Common Stock · 822 shares

Expires 2035-02-18

F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:09 UTC
Winters ChadVP, Chief Accounting Officer
Tax withholdingCommon Stock 27.727 $211.00 $5,850.40
Disclosure

SEC source: 0001127602-25-006118 · form4.xml · nonDerivative · entry 2

Winters Chad · CIK 0001811424 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,363.025

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:09 UTC
Winters ChadVP, Chief Accounting Officer
Exercise / conversionCommon Stock 82.054 $211.00 $17,313.39
Disclosure

SEC source: 0001127602-25-006118 · form4.xml · nonDerivative · entry 1

Winters Chad · CIK 0001811424 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,390.752

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:06 UTC
Green Eric MarkDirector · President, CEO and Board Chair
GrantRst. Stock Unit · Derivative 5,256 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-006115 · form4.xml · derivative · entry 4

Green Eric Mark · CIK 0001336007 · Director · President, CEO and Board Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,256

Underlying: Common Stock · 5,256 shares

Expires not disclosed

F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026.

F1 · derivative.expiration_date: This award vests in four equal installments beginning on February 18, 2026.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:06 UTC
Green Eric MarkDirector · President, CEO and Board Chair
GrantStock Option (Right to Buy) · Derivative 12,149 $0.00 Strike: $211.00 $0.00
Disclosure

SEC source: 0001127602-25-006115 · form4.xml · derivative · entry 3

Green Eric Mark · CIK 0001336007 · Director · President, CEO and Board Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,149

Underlying: Common Stock · 12,149 shares

Expires 2035-02-18

F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:06 UTC
Green Eric MarkDirector · President, CEO and Board Chair
Tax withholdingCommon Stock 700.296 $211.00 $147,762.46
Disclosure

SEC source: 0001127602-25-006115 · form4.xml · nonDerivative · entry 2

Green Eric Mark · CIK 0001336007 · Director · President, CEO and Board Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,668.8195

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:06 UTC
Green Eric MarkDirector · President, CEO and Board Chair
Exercise / conversionCommon Stock 2,460.991 $211.00 $519,269.10
Disclosure

SEC source: 0001127602-25-006115 · form4.xml · nonDerivative · entry 1

Green Eric Mark · CIK 0001336007 · Director · President, CEO and Board Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,369.1155

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:08 UTC
Witherspoon CharlesVP & Treasurer
GrantRst. Stock Unit · Derivative 237 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-25-006117 · form4.xml · derivative · entry 4

Witherspoon Charles · CIK 0001731739 · VP & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 237

Underlying: Common Stock · 237 shares

Expires not disclosed

F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026.

F1 · derivative.expiration_date: This award vests in four equal installments beginning on February 18, 2026.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 02:08 UTC
Witherspoon CharlesVP & Treasurer
GrantStock Option (Right to Buy) · Derivative 548 $0.00 Strike: $211.00 $0.00
Disclosure

SEC source: 0001127602-25-006117 · form4.xml · derivative · entry 3

Witherspoon Charles · CIK 0001731739 · VP & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 548

Underlying: Common Stock · 548 shares

Expires 2035-02-18

F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.